The FDA has warned that ketamine and compounded ketamine products aren’t approved to take care of any psychiatric disorder. This indicates that they haven’t been proven to get safe or helpful. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but https://andyz123xrp8.oneworldwiki.com/user